Red Flags Detected

  • Going Concern (new) — Company disclosed substantial doubt about ability to continue as a going concern for the first time in FY2026, citing $67.1M accumulated deficit and $12.3M operating cash burn.
  • Material Weakness (unchanged) — Material weaknesses in segregation of duties, technology controls, and financial reporting persist from prior year with no remediation disclosed.
NASDAQ: AMIX Autonomix Medical, Inc. 10-K

Autonomix pauses trial after mixed results, adds going-concern warning, extends runway to Q4 2026

Filed May 27, 2026 · Period ending March 31, 2026 · Compared to 10-K May 29, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade AMIX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 30, 2026 1:49 AM